New research by Oregon Health & Science University scientists has uncovered multiple factors to improve gene delivery to the ...

However, the therapeutic effect of exosome-mediated siRNA has not been tested in Huntington’s disease. Aims To explore the therapeutic potential of exosome-mediated siRNA delivery in BACHD and ...

10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 ... With Gene Editing, Mice With a Form of Inherited Deafness Can Hear Again July 12, 2024 — Researchers have used gene ...

10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 ... 9, 2024 — Studying the cells of people and genetically engineered mice, scientists say they have uncovered a potential ...

The accumulation of lipids in hepatocytes in nonalcoholic fatty liver disease (NAFLD) leads to an increase in reactive oxygen species and changes in the intracellular microenvironment, while ...

The research also revealed that the therapy’s effectiveness depends on a receptor called SR-A1. In mice that lacked this ...

But MORF-057 is a pill; Entyvio is administered via an intravenous infusion or under-the-skin shot ... which regularly ...

Her team recently developed a small nanocarrier that actively delivers a poly (ADP-ribose) polymerase (PARP) inhibitor and a ...

Evidence for this innate resistance to systemic therapies was recently provided in an accurate mouse model of PDA by the demonstration that chemotherapies are poorly delivered to PDA tissues because ...